CABIO will remain committed to the research and production of HMOs, aiming to diversify their applications in the end market and provide a wider range of healthy choices for individuals across different age groups CABIO unveiled an exciting new product range, NeoHMOs™, at the FIE 2023. CABIO team’s successful development[Read More…]
Tag: HMOs
China’s MARA to approve FrieslandCampina Ingredients’ 2’-FL production strain
Final nutrition fortifier approval of Aequival 2’-FL will mean FrieslandCampina Ingredients will soon become the only provider of both human milk oligosaccharides (HMOs) and galacto-oligosaccharides (GOS) in China Manufacturers of tot formula in China will soon be able to access a unique range of prebiotic ingredients, following the approval of FrieslandCampina[Read More…]
